Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saana Eskelinen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The American Journal of Psychiatry|February 4, 2009
Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosisGrigori Joffe, Saana Eskelinen, Eila Sailas
Nordic Journal of Psychiatry|August 27, 2016
Dyspepsia and constipation in patients with schizophrenia spectrum disordersTomi Virtanen, Saana Eskelinen, Eila Sailas, et al.
Current Diabetes Reports|January 25, 2016
Diabetes and SchizophreniaJaana Suvisaari, Jaakko Keinänen, Saana Eskelinen, et al.
Annals of General Psychiatry|December 14, 2020
Physical health examination in outpatients with schizophrenia: the cost effectiveness of laboratory screening testsSaana Eskelinen, Janne V J Suvisaari, Jaana M Suvisaari
Nordic Journal of Psychiatry|May 19, 2015
Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophreniaSaana Eskelinen, Eila Sailas, Kaisla Joutsenniemi, et al.
Nordic Journal of Psychiatry|November 30, 2025
Alcohol use, daily smoking, clozapine use and psychiatric symptom profile in persons with schizophrenia spectrum disorderJonna Levola, Sari Lång-Tonteri, Solja Niemelä, et al.
Nordic Journal of Psychiatry|May 13, 2017
Multiple physical healthcare needs among outpatients with schizophrenia: findings from a health examination studySaana Eskelinen, Eila Sailas, Kaisla Joutsenniemi, et al.
Acta Psychiatrica Scandinavica|August 29, 2024
Psychosis metabolic risk calculator (PsyMetRiC) in early psychosis: External validation study in FinlandJaakko Keinänen, Saana Eskelinen, Tiina From, et al.
Nature|April 9, 2022
Rare coding variants in ten genes confer substantial risk for schizophreniaTarjinder Singh, Timothy Poterba, David Curtis, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The American Journal of Psychiatry|February 4, 2009
Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosisGrigori Joffe, Saana Eskelinen, Eila Sailas
Nordic Journal of Psychiatry|August 27, 2016
Dyspepsia and constipation in patients with schizophrenia spectrum disordersTomi Virtanen, Saana Eskelinen, Eila Sailas, et al.
Current Diabetes Reports|January 25, 2016
Diabetes and SchizophreniaJaana Suvisaari, Jaakko Keinänen, Saana Eskelinen, et al.
Annals of General Psychiatry|December 14, 2020
Physical health examination in outpatients with schizophrenia: the cost effectiveness of laboratory screening testsSaana Eskelinen, Janne V J Suvisaari, Jaana M Suvisaari
Nordic Journal of Psychiatry|May 19, 2015
Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophreniaSaana Eskelinen, Eila Sailas, Kaisla Joutsenniemi, et al.
Nordic Journal of Psychiatry|November 30, 2025
Alcohol use, daily smoking, clozapine use and psychiatric symptom profile in persons with schizophrenia spectrum disorderJonna Levola, Sari Lång-Tonteri, Solja Niemelä, et al.
Nordic Journal of Psychiatry|May 13, 2017
Multiple physical healthcare needs among outpatients with schizophrenia: findings from a health examination studySaana Eskelinen, Eila Sailas, Kaisla Joutsenniemi, et al.
Acta Psychiatrica Scandinavica|August 29, 2024
Psychosis metabolic risk calculator (PsyMetRiC) in early psychosis: External validation study in FinlandJaakko Keinänen, Saana Eskelinen, Tiina From, et al.
Nature|April 9, 2022
Rare coding variants in ten genes confer substantial risk for schizophreniaTarjinder Singh, Timothy Poterba, David Curtis, et al.
Pageof 1